• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

THE ROLE OF HEPATITIS C VIRUS BY INDUCTION OF CARDIOMYOPATHY

Research Project

Project/Area Number 13670547
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOSAKA CITY UNIVERSITY

Principal Investigator

SHIOMI Susumu  OSAKA CITY UNIVERSITY, GARDUATE SCHOOL OF MEDICINE, DEPARTMENT OF NUCLEAR MEDICINE, PROFESSOR, 大学院・医学研究科, 教授 (30170848)

Co-Investigator(Kenkyū-buntansha) YOSHIYAMA Minoru  OSAKA CITY UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, DEPARTMENT OF CARDIOLOGY, ASSOCIATE PROFESSOR, 大学院・医学研究科, 助教授 (30240956)
NISHIGUCHI Shuhei  OSAKA CITY UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, DEPARTMENT OF HEPATOLOGY, ASSOCIATE PROFESSOR, 大学院・医学研究科, 助教授 (10192246)
Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2002: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2001: ¥1,300,000 (Direct Cost: ¥1,300,000)
KeywordsCARDIOMYOPATHY / HEPATITIS C VIRUS / TRANSGENIC MOUSE / HCV CORE PROTEIN / HCV ANTIBODY / HCV GENOTYPE / HCV-RNA / CARDIOMYOCYTE / AP-1 / 肥大性心筋症 / 培養心筋細胞 / 肥大型心筋症 / HCV-RNA
Research Abstract

Hepatitis C virus (HCV) is the main cause of chronic hepatitis worldwide. HCV has been reported to be associated with cardiomyopathy. However, the mechanism of cardiomyopathy in chronic HCV infection is still unclear. The ability of the core protein of HCV to modulate gene transcription, cell growth and cell death may be involved in the pathogenesis of cardiomyopathy.
Here, we report the development of cardiomyopathy in mice transgenic for the HCV core gene. After the age of 12 months, mice developed cardiomyopathy that appeared as left ventricular dilatation, and systolic and diastolic dysfunction. These cardiac changes were consisted with cardiomyocyte hypertrophy, myofiber disorganization, myofilament loss, myofiber disorganization, Z-band abnormalities, irregular shaped nuclei, increased number of mitochondria and aggregation of mitochondria.
These results indicate that the HCV core protein has an important role in the development of cardiomyopathy, and that these transgenic mice provide good animal models for cardiomyopathy with HCV infection.

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 西口修平, 他: "循環器疾患におけるHCV抗体陽性率の検討-心筋症との比較"厚生科学研究費・非A非B型肝炎の臨床的総合研究・平成10〜12年度報告書. 160-161 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tragaki M, et al.: "Prevalence of hepatitis C virus infection among patients with Hypertrophic cardiomyopathy"Heart & Vessels. 18. 167-170 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Omura, et al.: "The core protein of hepatitis C virus induced cardiomyopathy in transgenic mice"J Med Virol. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 西口修平, 他: "HCVトランスジェニックマウスにおける心筋症の検討"厚生科学研究費・新興・再感染症研究事業分担研究報告書・平成15年度報告書. (印刷中). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishiguchi S, Fukuda K, Shiomi S, Teragaki M, Yoshiyama M, Yoshikawa j.: "Incidence of hepatitis C virus antibody in patients with hypertrophic cardiomyopathy"Annual Report of Ministry of Health, Labour and Welfare. 160-161 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Teragaki M, Nishiguchi S, Takeuchi K, Yoshiyama M, Akioka K, Yoshikawa J.: "Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopath"Heart Vessels. 18. 167-170 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishiguchi S, Fukuda K, Shiomi S, Teragaki M, Yoshiyama M, Yoshikawa J.: "Evaluation of cardiomyopathy in hepatitis C virus transgenic mouse"Annual Report of Ministry of Health, Labour and Welfare. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Omura T, Yoshiyama M, Hayashi T, Nishiguchi S, Fukuda K, Inamoto S, Nakamura y, Teragaki M, Iwao H, Takeuchi K, Yoshikawa J.: "The core protein of hepatitis C virus induced cardiomyopathy in transgenic mice"

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Teragaki M, et al.: "Prevalence of hepatitis C virus among patients with hypertrophic cardiomyopathy"Heart & Vessels. 18. 167-170 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 西口修平, 他: "HCVトランスジェニックマウスにおける心筋症の検討"厚生科学研究補助金、新興・再感染症研究事業.分担報告書 平成15年度研究報告書. (印刷中). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Teragaki M et al.: "Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy"Heart & Vessels. (in press).

    • Related Report
      2002 Annual Research Report
  • [Publications] 西口修平他: "循環器疾患におけるHCV抗体陽性率の検討-心筋症と他疾患の比較"厚生科学研究費・非A非B型肝炎の臨床的総合研究・平成10〜12年度報告書. 160-161 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi